NRS
MDT icon

Neville Rodie & Shaw’s Medtronic MDT Stock Holding History

Neville Rodie & Shaw’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$717K Hold
9,164
– – 0.05% 151
2026
Q1 		$794K Sell
9,164
-30
-0.3% -$2.87K 0.06% 140
2025
Q4 		$883K Buy
9,194
+30
+0.3% +$2.91K 0.06% 136
2025
Q3 		$873K Sell
9,164
-140
-2% -$12.9K 0.06% 138
2025
Q2 		$811K Sell
9,304
-382
-4% -$32.4K 0.06% 142
2025
Q1 		$870K Sell
9,686
-849
-8% -$76K 0.07% 140
2024
Q4 		$842K Sell
10,535
-33
-0.3% -$2.86K 0.06% 144
2024
Q3 		$951K Sell
10,568
-3,160
-23% -$266K 0.07% 134
2024
Q2 		$1.08M Hold
13,728
– – 0.08% 129
2024
Q1 		$1.2M Hold
13,728
– – 0.09% 121
2023
Q4 		$1.13M Sell
13,728
-60
-0.4% -$4.57K 0.09% 124
2023
Q3 		$1.08M Hold
13,788
– – 0.1% 118
2023
Q2 		$1.22M Buy
13,788
+60
+0.4% +$5.17K 0.1% 112
2023
Q1 		$1.11M Sell
13,728
-815
-6% -$66.4K 0.1% 116
2022
Q4 		$1.13M Hold
14,543
– – 0.11% 115
2022
Q3 		$1.17M Sell
14,543
-36
-0.2% -$3.23K 0.12% 110
2022
Q2 		$1.31M Hold
14,579
– – 0.12% 109
2022
Q1 		$1.64M Hold
14,579
– – 0.12% 105
2021
Q4 		$1.51M Sell
14,579
-100
-0.7% -$11.6K 0.11% 114
2021
Q3 		$1.84M Buy
14,679
+400
+3% +$51.8K 0.14% 97
2021
Q2 		$1.77M Sell
14,279
-400
-3% -$50.2K 0.14% 100
2021
Q1 		$1.73M Sell
14,679
-700
-5% -$82K 0.14% 100
2020
Q4 		$1.8M Sell
15,379
-5,191
-25% -$571K 0.16% 91
2020
Q3 		$2.14M Buy
20,570
+226
+1% +$22.7K 0.2% 85
2020
Q2 		$1.86M Hold
20,344
– – 0.19% 86
2020
Q1 		$1.83M Hold
20,344
– – 0.22% 85
2019
Q4 		$2.31M Sell
20,344
-150
-0.7% -$16.5K 0.23% 92
2019
Q3 		$2.23M Buy
20,494
+349
+2% +$36.4K 0.24% 93
2019
Q2 		$1.96M Buy
20,145
+1,340
+7% +$122K 0.21% 96
2019
Q1 		$1.71M Buy
18,805
+36
+0.2% +$3.22K 0.18% 101
2018
Q4 		$1.71M Sell
18,769
-75
-0.4% -$7.01K 0.21% 95
2018
Q3 		$1.85M Sell
18,844
-700
-4% -$64.7K 0.18% 99
2018
Q2 		$1.67M Buy
19,544
+641
+3% +$53.5K 0.18% 101
2018
Q1 		$1.52M Hold
18,903
– – 0.17% 104
2017
Q4 		$1.53M Hold
18,903
– – 0.16% 108
2017
Q3 		$1.47M Hold
18,903
– – 0.16% 106
2017
Q2 		$1.68M Sell
18,903
-200
-1% -$16.9K 0.19% 101
2017
Q1 		$1.54M Sell
19,103
-1,200
-6% -$93.7K 0.18% 107
2016
Q4 		$1.45M Sell
20,303
-200
-1% -$15.7K 0.17% 104
2016
Q3 		$1.77M Hold
20,503
– – 0.21% 97
2016
Q2 		$1.78M Sell
20,503
-133
-0.6% -$10.8K 0.21% 95
2016
Q1 		$1.55M Hold
20,636
– – 0.19% 101
2015
Q4 		$1.59M Sell
20,636
-318
-2% -$23.9K 0.19% 99
2015
Q3 		$1.4M Hold
20,954
– – 0.17% 109
2015
Q2 		$1.55M Sell
20,954
-1,128
-5% -$86.2K 0.17% 115
2015
Q1 		$1.72M Buy
22,082
+1,359
+7% +$103K 0.18% 113
2014
Q4 		$1.5M Hold
20,723
– – 0.15% 117
2014
Q3 		$1.28M Hold
20,723
– – 0.13% 121
2014
Q2 		$1.32M Hold
20,723
– – 0.13% 119
2014
Q1 		$1.28M Buy
20,723
+418
+2% +$24.3K 0.14% 116
2013
Q4 		$1.17M Sell
20,305
-2,350
-10% -$133K 0.13% 120
2013
Q3 		$1.21M Sell
22,655
-2,775
-11% -$149K 0.14% 118
2013
Q2 		$1.31M Buy
+25,430
New +$1.26M 0.16% 112

Other funds holding MDT

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
MAA
Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Neville Rodie & Shaw's MDT Position: Q2 2026 in Review

Neville Rodie & Shaw held its Medtronic (MDT) position steady in Q2 2026 at 9,164 shares worth $717K. The position accounts for 0.05% of the portfolio, ranked #151.

Neville Rodie & Shaw first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.31M in Q4 2019. 535 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Neville Rodie & Shaw held 9,164 shares of Medtronic worth $717K as of Q2 2026.
  • Neville Rodie & Shaw left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.05% of Neville Rodie & Shaw's portfolio in Q2 2026, its #151 holding.
  • Neville Rodie & Shaw first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Neville Rodie & Shaw's Medtronic position peaked at $2.31M in Q4 2019.
  • 535 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Neville Rodie & Shaw's 13F filing for Q2 2026, filed 6 Jul 2026.